The UN General Assembly passed a resolution on April 18 urging governments to accelerate efforts to roll back malaria worldwide, particularly in Africa, a move welcomed by WWARN. The action preceded World Malaria Day on 25 April.
WWARN has unveiled a suite of online tools that will give an up-to-date and global picture of the emergence and spread of antimalarial resistance. WWARN is appealing to malaria researchers around the world to collaborate on sharing data and to use these tools to monitor and control the disease.
Griffith Pugh was an eccentric Welsh physiologist who was instrumental in the successful 1953 Everest climb by Ed Hillary and Tenzing Norgay. He was so absent minded that he was wearing pajamas when John Hunt’s team was formally presented to King Tribhuvan after their Everest climb
Viet Nam's first ever Science Café took place on 5 March 2011 at the University of Medicine and Pharmacy HCMC, posing the question “Why does medical research need ethics?”, moderated by Professor Tran Tinh Hien, Director of Clinical Research at the Oxford University Clinical Research Unit (OUCRU). Fifty five 4th to 6th year medical students from UMP participated.
Dr Emelda Okiro of the Nairobi based Malaria and Public Health Epidemiology Group (MHEG) has been awarded a prestigious Post-doctoral Fellowship in Washington. She will be based at the Institute for Health Metrics and Evaluation (IHME) in Washington, which is one of the leading global health research centres based at the Department of Global Health at the University of Washington and is renowned for its its work in generating high quality information on population health, its determinants, and the performance of health systems.
Israeli researchers say they have developed a powerful bait that effectively attracts and kills malaria-infected mosquitoes but is completely harmless to humans and other animals
WWARN's mission to facilitate data sharing among the malaria commmunity is referenced in the latest issue of Science. The article by Trudie Lang of Global Health Trials at the University of Oxford, looks at the use of digital technologies to facilitate collaborative research in remote places with limited access to resources.
Clinical trials for a single-dose cure for malaria and artemisinin-resistant parasites have progressed successfully to phase 2. The novel synthetic peroxide antimalarial drug candidate, OZ439 has been developed through a partnership between Medicines for Malaria Venture (MMV), University of Nebraska Medical Centre, Monash University and the Swiss Tropical and Public Health Institute.
The Malaria Eradication Research Agenda (malERA) initiative has launched a new multidisciplinary research and development agenda for eradicating malaria, based on a two-year consultative process involving more than 250 scientists. The collection of articles is published under the title ‘A research agenda for Malaria Eradication’ in PLoS Medicine.
Last week, the United Nations announced a new plan of action designed to help fight disease resistance to artemisinin, the world’s most potent treatment for malaria. Launched by the UN World Health Organization (WHO) and the Roll Back Malaria Partnership (RBM), the groups hope to better contain and prevent resistance to artemisinins, the critical component of artemisinin-based combination therapies (ACTs), which are currently the most effective weapon in treating falciparum malaria.